2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Genitourinary
1
Conditions
Neoplasms
6
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Cardiovascular Diseases
2
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Intraepithelial Neoplasia
1
Osteoporosis
1
Neuralgia
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Motor Activity
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Eye Diseases
1
Cognitive Dysfunction
1
Breast Neoplasms, Male
1
Bone Diseases, Metabolic
1
Blast Crisis
1
Interventions
Fluorouracil
497
Bevacizumab
476
Oxaliplatin
449
Leucovorin
440
Irinotecan
408
Cetuximab
317
Capecitabine
317
pembrolizumab
142
Folfox protocol
129
Panitumumab
117
regorafenib
105
Colonoscopy
88
Nivolumab
81
IFL protocol
81
Drug Therapy
77
trifluridine tipiracil drug combination
73
Radiotherapy
66
HMPL-013
65
Blood Specimen Collection
52
Gemcitabine
49
Specimen Handling
46
Neoadjuvant Therapy
45
Standard of Care
44
Magnetic Resonance Spectroscopy
43
Biopsy
43
Chemotherapy, Adjuvant
41
Trifluridine
40
atezolizumab
38
Surveys and Questionnaires
38
Cyclophosphamide
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Geritol
×
Clear all
NCT07341217
2026-01-14
CHEMOBRAIN
Lancaster University
Phase NA
Not yet recruiting
86 enrolled
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled